Maximizing the Treatment Benefit of tDCS in Neurodegenerative Anomia

Carlos Roncero1,2, Erik Service2, Marco De Caro2

  • 1Rotman Research Institute, Baycrest Health Sciences, Toronto, ON, Canada.

Frontiers in Neuroscience
|December 12, 2019
PubMed